相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity
Iulia Oancea et al.
GUT (2013)
Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients
Maria Chaparro et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease
Ana C. Tuyama et al.
JOURNAL OF CROHNS & COLITIS (2013)
Treatment with adalimumab in a patient with regenerative nodular hyperplasia secondary to azathioprine
Rafael León-Montañes et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2013)
Portal hypertension in nodular regenerative hyperplasia: A mixed bag!
Ajay Duseja et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension
Julien Bissonnette et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Management of hepatic vascular diseases
Aurélie Plessier et al.
JOURNAL OF HEPATOLOGY (2012)
Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Liver transplantation for the treatment of nodular regenerative hyperplasia
Tommaso Maria Manzia et al.
DIGESTIVE AND LIVER DISEASE (2011)
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis
Dirk P. van Asseldonk et al.
DIGESTIVE AND LIVER DISEASE (2011)
Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease
Cristina Lopez-Martin et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2011)
Idiopathic Noncirrhotic Portal Hypertension
Jeoffrey N. L. Schouten et al.
HEPATOLOGY (2011)
Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease
Wojciech Blogowski et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
Incidence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Azathioprine
Philippe Seksik et al.
INFLAMMATORY BOWEL DISEASES (2011)
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease
Emma Calabrese et al.
JOURNAL OF CROHNS & COLITIS (2011)
Obliterative portal venopathy: Portal hypertension is not always present at diagnosis
Dominique Cazals-Hatem et al.
JOURNAL OF HEPATOLOGY (2011)
Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of Vigilance
Francesco Di Fabio et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)
Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension
Marek Hartleb et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Radiologic Mimics of Cirrhosis
Priyanka Jha et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial
Linda C. Stork et al.
BLOOD (2010)
Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver
David Laharie et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Low Inter-Observer Agreement on Nodular Regenerative Hyperplasia of the Liver: An European Inter-Observer Analysis
Bindia Jharap et al.
GASTROENTEROLOGY (2010)
Thiopurine Therapy in Inflammatory Bowel Disease Patients: Analyses of Two 8-Year Intercept Cohorts
B. Jharap et al.
INFLAMMATORY BOWEL DISEASES (2010)
6-Thioguanine therapy in Crohn's disease-Observational data in Swedish patients
S. H. C. Almer et al.
DIGESTIVE AND LIVER DISEASE (2009)
Vascular Disorders of the Liver
Laurie D. DeLeve et al.
HEPATOLOGY (2009)
Portal vein hypertension with azathioprine therapy in patients with Crohn's disease - is it a frequent phenomenon?
L. Ehmsen et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Nodular regenerative hyperplasia:: a side effect of azathioprine in a patient with Crohn's disease
M. Schumann et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients
N. K. H. de Boer et al.
DIGESTIVE AND LIVER DISEASE (2008)
Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine
Erik H. C. J. Buster et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Further Experience with the Use of 6-Thioguanine in Patients with Crohn's Disease
Azhar Ansari et al.
INFLAMMATORY BOWEL DISEASES (2008)
Evidence for a Role of Epithelial Mesenchymal Transition During Pathogenesis of Fistulae in Crohn's Disease
Frauke Bataille et al.
INFLAMMATORY BOWEL DISEASES (2008)
Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia
Nanne K. H. De Boer et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
Nanne K. H. de Boer et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients
Omid A. Shaye et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension
Arnulf Ferlitsch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
G. Vernier-Massouille et al.
GUT (2007)
Liver injury in inflammatory Bowel disease:: Long-term follow-up study of 786 patients
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2007)
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative children's oncology group/National Cancer Institute Pilot Trial (CCG-1942)
Shana S. Jacobs et al.
PEDIATRIC BLOOD & CANCER (2007)
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease
Alexander Teml et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques
Christoph J. Zech et al.
EUROPEAN RADIOLOGY (2007)
Thiopurine-induced liver injury in patients with inflammatory bowel disease:: A systematic review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Toxicity of 6-thioguanine:: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine -: Some evidence for dose or metabolite level dependent effects?
L. P. L. Gilissen et al.
DIGESTIVE AND LIVER DISEASE (2007)
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia
Lynne Lennard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Nodular regenerative hyperplasia: Not all nodules are created equal
Preeti A. Reshamwala et al.
HEPATOLOGY (2006)
Nodular regenerative hyperplasia:: a reversible entity associated with azathioprine therapy
Julia Seiderer et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia
R De Bruyne et al.
JOURNAL OF HEPATOLOGY (2006)
6-thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party
NKH de Boer et al.
DIGESTION (2006)
Thiopurine therapies - Problems, complexities, and progress with monitoring thioguanine nucleotides
John A. Duley et al.
THERAPEUTIC DRUG MONITORING (2005)
Nodular regenerative hyperplasia and thiopurines: The case for level-dependent toxicity
NKH de Boer et al.
LIVER TRANSPLANTATION (2005)
On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients
Nanne K. H. de Boer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine
J Seiderer et al.
JOURNAL OF HEPATOLOGY (2005)
Thrombosis and inflammatory bowel disease
PM Irving et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Azathioprine induced nodular regenerative hyperplasia in IBD patients
F Daniel et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2005)
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations
AFY Al Hadithy et al.
DIGESTIVE AND LIVER DISEASE (2005)
Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease
S Kane et al.
INFLAMMATORY BOWEL DISEASES (2004)
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease
SA Geller et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia
B Piel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia
S Stoneham et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine
M Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
MC Dubinsky et al.
GASTROENTEROLOGY (2003)
Inflammation and thrombosis
CT Esmon
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Remission maintenance by tioguanine in chronic active Crohn's disease
KR Herrlinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment
LJJ Derijks et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients
S Hillaire et al.
GUT (2002)
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy
MC Dubinsky et al.
INFLAMMATORY BOWEL DISEASES (2001)
Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis
S Russmann et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury
IDR Arnott et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
分享论文
